Modified double-volume exchange transfusion in 2 infants with severe pertussis and hyperleukocytosis

Si-Meng Wu1, Qiu-Shi Wang1

  • 1Department of Blood Transfusion, Shengjing Hospital of China Medical University, Shenyang, China.

Laboratory Medicine
|June 11, 2026
PubMed

Insights

Modified exchange transfusion effectively treated severe pertussis (whooping cough) in infants with high white blood cell counts. This procedure improved breathing and reduced white blood cell levels safely, leading to successful recovery.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Hematology

Background:

  • Pertussis, caused by Bordetella pertussis, is an acute respiratory illness.
  • Hyperleukocytosis in pertussis worsens prognosis, leading to pulmonary hypertension, multiorgan failure, and increased mortality.
  • Exchange transfusion is a potential treatment to improve outcomes in pediatric pertussis.

Purpose of the Study:

  • To evaluate the safety and efficacy of a modified exchange transfusion in infants with severe pertussis and hyperleukocytosis.

Main Methods:

  • Retrospective analysis of 2 infants with severe pertussis treated with modified exchange transfusion.
  • Preparation of reconstituted whole blood with specific ratios of leukoreduced red blood cells and plasma.
  • Total exchange volume of 150-180 mL/kg (approximately 2 blood volumes).

Main Results:

  • Both infants experienced a significant reduction in white blood cell count post-transfusion.
  • Clinically significant improvement in dyspnea was observed in both patients.
  • No severe adverse reactions were reported, and both infants were discharged.

Conclusions:

  • Modified double-volume exchange transfusion is a safe and effective therapeutic option for infants suffering from severe pertussis complicated by hyperleukocytosis.
Abstract

Related Concept Videos

Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
Acute Respiratory Failure-IV01:23

Acute Respiratory Failure-IV

Respiratory failure can manifest suddenly or gradually, characterized by a rapid decline in PaO2 and a rapid rise in PaCO2. This situation indicates a severe respiratory problem that may quickly become a life-threatening emergency. One of the early signs of hypoxemic Acute Respiratory Failure (ARF) is a change in mental status due to the brain's sensitivity to oxygen levels and changes in acid-base balance. Symptoms such as restlessness, confusion, and agitation suggest inadequate oxygen...
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without causing...
Blood Transfusion and Agglutination02:45

Blood Transfusion and Agglutination

Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...